Literature DB >> 2083608

[Mild infrared A hyperthermia in treatment of systemic scleroderma].

H Meffert1, I Buchholtz, A Brenke.   

Abstract

Seven female systemic sclerosis patients (all from acrosclerosis type, with intestinal involvement, and marked Raynaud phenomenon) were treated with infrared A whole body irradiations (wavelengths between 800 and 1,400 nm, 12 W/dm2 maximally). The single exposure lasted for 30 minutes and resulted in an 0.9 degrees C rise of central body temperature. Acral skin rewarming became regular immediately after irradiation and kept improved, as compared with pre-treatment values, for at least 18 weeks. All the patients told about a comfortable feeling of warmth after each treatment lasting for one two days. Three out of the seven reported lower frequency and severity of Raynaud attacks.

Entities:  

Mesh:

Year:  1990        PMID: 2083608

Source DB:  PubMed          Journal:  Dermatol Monatsschr        ISSN: 0011-9083


  6 in total

1.  The other end of the rainbow: infrared and skin.

Authors:  Aton M Holzer; Mohammad Athar; Craig A Elmets
Journal:  J Invest Dermatol       Date:  2010-06       Impact factor: 8.551

2.  Principles and working mechanisms of water-filtered infrared-A (wIRA) in relation to wound healing.

Authors:  Gerd Hoffmann
Journal:  GMS Krankenhhyg Interdiszip       Date:  2007-12-28

3.  Therapy of chronic wounds with water-filtered infrared-A (wIRA).

Authors:  Verena von Felbert; Hauke Schumann; James B Mercer; Wolfgang Strasser; Georg Daeschlein; Gerd Hoffmann
Journal:  GMS Krankenhhyg Interdiszip       Date:  2008-03-05

4.  Therapy of acute wounds with water-filtered infrared-A (wIRA).

Authors:  Mark Hartel; Peter Illing; James B Mercer; Jürgen Lademann; Georg Daeschlein; Gerd Hoffmann
Journal:  GMS Krankenhhyg Interdiszip       Date:  2007-12-28

5.  [Photoaging and infrared radiation. Novel aspects of molecular mechanisms].

Authors:  S M Schieke
Journal:  Hautarzt       Date:  2003-09       Impact factor: 0.751

6.  Water-filtered infrared-A (wIRA) can act as a penetration enhancer for topically applied substances.

Authors:  Nina Otberg; Diego Grone; Lars Meyer; Sabine Schanzer; Gerd Hoffmann; Hanns Ackermann; Wolfram Sterry; Jürgen Lademann
Journal:  Ger Med Sci       Date:  2008-07-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.